125 related articles for article (PubMed ID: 6641086)
21. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of isosorbide dinitrate in healthy volunteers after 24-hour intravenous infusion.
Bergami A; Bernasconi R; Caccia S; Leopaldi D; Mizrahi J; Sardina M; Urso R; Warrington SJ; Latini R
J Clin Pharmacol; 1997 Sep; 37(9):828-33. PubMed ID: 9549637
[TBL] [Abstract][Full Text] [Related]
23. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
Straehl P; Galeazzi RL; Soliva M
Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
[TBL] [Abstract][Full Text] [Related]
24. Newer aspects of the pharmacokinetics of organic nitrates.
Chasseaud LF
Z Kardiol; 1983; 72 Suppl 3():20-3. PubMed ID: 6666223
[TBL] [Abstract][Full Text] [Related]
25. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].
Menke G; Schnellhammer R; Rietbrock N
Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041
[TBL] [Abstract][Full Text] [Related]
26. A pharmacokinetic model for isosorbidedinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate.
Smith D; Aldrich W; Dey M; Enever R; Warner R; Weierstall R
Drug Metab Dispos; 1990; 18(4):429-34. PubMed ID: 1976063
[TBL] [Abstract][Full Text] [Related]
27. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
Laufen H; Leitold M
Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
[TBL] [Abstract][Full Text] [Related]
28. Isosorbide dinitrate: relationship between pharmacokinetics and brachial artery hemodynamics in essential hypertension.
Frydman AM; Safar ME; Simon AC; Levenson JA; Gaillot J; Roland E
Angiology; 1986 Aug; 37(8):581-91. PubMed ID: 3740548
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacodynamic effects of the sustained-release tablet of isosorbide dinitrate and its bioavailability in conscious dogs (author's transl)].
Kogi K; Chida S; Kimura T; Saito T
Nihon Yakurigaku Zasshi; 1980 Mar; 76(2):99-107. PubMed ID: 7399370
[TBL] [Abstract][Full Text] [Related]
30. Determination of isosorbide dinitrate biotransformation in various tissues of the rabbit by capillary column gas-liquid chromatography.
Tam GS; Nakatsu K; Brien JF; Marks GS
Biopharm Drug Dispos; 1987; 8(1):37-45. PubMed ID: 3580511
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacokinetics of isosorbide dinitrate administered by intravenous infusion to hypertensive patients (author's transl)].
Frydman A; Levenson J; Simon A; Safar M; Bieder A; Bertharion J; Gaillot J
Nouv Presse Med; 1982 Jun; 11(27):2049-56. PubMed ID: 7110964
[TBL] [Abstract][Full Text] [Related]
32. Sex-related difference in the metabolism of isosorbide dinitrate following incubation in human blood.
Bennett BM; Twiddy DA; Moffat JA; Armstrong PW; Marks GS
Biochem Pharmacol; 1983 Dec; 32(24):3729-34. PubMed ID: 6661248
[TBL] [Abstract][Full Text] [Related]
33. Effects and pharmacokinetics of isosorbide dinitrate in normal man.
Spörl-Radun S; Betzien G; Kaufmann B; Liede V; Abshagen U
Eur J Clin Pharmacol; 1980 Oct; 18(3):237-44. PubMed ID: 7439242
[TBL] [Abstract][Full Text] [Related]
34. Isosorbide 5-mononitrate kinetics.
Major RM; Taylor T; Chasseaud LF; Darragh A; Lambe RF
Clin Pharmacol Ther; 1984 May; 35(5):653-9. PubMed ID: 6713775
[TBL] [Abstract][Full Text] [Related]
35. Effects of disease, route of administration, cigarette smoking, food intake on the pharmacokinetics and circulatory effects of isosorbide dinitrate.
Fung HL; Ruggirello D; Stone JA; Parker JO
Z Kardiol; 1983; 72 Suppl 3():5-10. PubMed ID: 6666234
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
Schaumann W
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
[TBL] [Abstract][Full Text] [Related]
37. Isosorbide dinitrate in plasma and dialysate during haemodialysis.
Bauer H; Laufen H; Franz HE
Eur J Clin Pharmacol; 1986; 30(2):187-90. PubMed ID: 3709643
[TBL] [Abstract][Full Text] [Related]
38. Patterns of isosorbide dinitrate and glyceryl trinitrate metabolites formed by selected segments of the rabbit gastrointestinal tract.
Tam GS; MacMillan H; Bennett BM; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1988 Feb; 66(2):166-70. PubMed ID: 3130974
[TBL] [Abstract][Full Text] [Related]
39. [Bioavailability and bioequivalence of organic nitrates. Isosorbide dinitrate--a study of sustained-release preparations].
Scheidel B; Blume H; Stenzhorn G; Siewert M; Babej-Dölle RM
Arzneimittelforschung; 1991 Mar; 41(3):212-8. PubMed ID: 1867657
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of three organic nitrates in Chinese healthy male volunteers.
Chen J; Jiang XG; Cai L; Lu W; Gao KP; Shi ZQ; Zhang QZ
Arzneimittelforschung; 2004; 54(4):203-6. PubMed ID: 15146932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
